Laboratory testing in the evaluation and diagnosis of vasculitis
- PMID: 11123092
- DOI: 10.1007/s11926-000-0042-6
Laboratory testing in the evaluation and diagnosis of vasculitis
Abstract
A multitude of tests are available for the diagnosis and management of the vasculitides. Most of them are nonspecific but provide useful information that, when appropriately used in conjunction with the patient's history and physical examination can be of great assistance in arriving at a final diagnosis. In addition, information gathered may be of great help in monitoring disease activity and clinical response to therapy, in indicating the presence of specific organ system involvement, in monitoring toxicity of medication used, and in assessing prognosis. Serial measurements of acute phase reactants, complete blood cell count with differential, biochemistry profiles, urinalysis, and C3 and C4 levels should be obtained in all patients. Antineutrophil cytoplasmic antibodies (ANCA) determination provides valuable information and is highly specific for the diagnosis of small-vessel vasculitides, particularly Wegener's granulomatosis and microscopic polyangiitis. ANCA levels can be particularly useful to assess disease activity in these disorders. Hepatitis-B and, more importantly, hepatitis-C testing is extremely useful, particularly in the presence of liver involvement and associated risk factors. Angiographic studies may confirm the diagnosis, particularly if there is laboratory and clinical evidence of specific organ involvement. It should be noted, however, that angiography may be normal even when vasculitis is present, or the findings may be nonspecific. A definite diagnosis is provided by a tissue biopsy. This should be performed whenever there is access to clinically affected tissue.
Similar articles
-
[ANCA-associated forms of vasculitis].Verh Dtsch Ges Pathol. 1996;80:38-45. Verh Dtsch Ges Pathol. 1996. PMID: 9065053 Review. German.
-
Antineutrophil cytoplasmic antibodies.Lancet. 2006 Jul 29;368(9533):404-18. doi: 10.1016/S0140-6736(06)69114-9. Lancet. 2006. PMID: 16876669 Review.
-
[Antineutrophil cytoplasmic antibodies].Reumatismo. 2009 Jan-Mar;61(1):69-76. doi: 10.4081/reumatismo.2009.69. Reumatismo. 2009. PMID: 19370191 Italian.
-
Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.J Intern Med. 1998 Aug;244(2):133-41. doi: 10.1046/j.1365-2796.1998.00324.x. J Intern Med. 1998. PMID: 10095799
-
Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.Wien Klin Wochenschr. 2000 Aug 25;112(15-16):665-70. Wien Klin Wochenschr. 2000. PMID: 11020953
Cited by
-
Systemic Lupus Erythematosus Vasculitis: A Current Therapeutic Overview.Curr Treat Options Cardiovasc Med. 2004 Apr;6(2):87-97. doi: 10.1007/s11936-004-0036-1. Curr Treat Options Cardiovasc Med. 2004. PMID: 15066237
-
Vasculitis associated with connective tissue disorders.Curr Rheumatol Rep. 2006 Aug;8(4):312-6. doi: 10.1007/s11926-006-0015-5. Curr Rheumatol Rep. 2006. PMID: 16839511 Review.
-
Lupus vasculitis: differential diagnosis with antiphospholipid syndrome.Curr Rheumatol Rep. 2002 Feb;4(1):18-24. doi: 10.1007/s11926-002-0019-8. Curr Rheumatol Rep. 2002. PMID: 11798978 Review.
-
Lupus-related vasculitis in a cohort of systemic lupus erythematosus patients.Arch Rheumatol. 2021 Oct 12;36(4):595-692. doi: 10.46497/ArchRheumatol.2021.8804. eCollection 2021 Dec. Arch Rheumatol. 2021. PMID: 35382370 Free PMC article.
-
Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.Clin J Am Soc Nephrol. 2013 Nov;8(11):1884-91. doi: 10.2215/CJN.02790313. Epub 2013 Oct 10. Clin J Am Soc Nephrol. 2013. PMID: 24115193 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous